PREEMPTIVE ADMINISTRATION OF JAK1/2 INHIBITOR RUXOLITINIB RAPIDLY AMELIORATE GVHD AFTER ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Ting Yang, 293894

INVASIVE FUNGAL DISEASE CHARACTERISTICS IN ADULT HEMATOLOGICAL MALIGNANCY PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RESULTS OF NATION-WIDE CROSS-SECTIONAL 2012-2014

EHA Library, Patrycja Mensah-Glanowska, 293895

ALEMTUZUMAB FOR IN VIVO T-CELL DEPLETION IN UNRELATED DONOR ALLOGENEIC STEM CELL TRANSPLANTATION: DECREASING THE DOSE FROM 60 MG TO 30 MG RESULTS IN EQUIVALENT OUTCOMES

EHA Library, Sara Lozano, 293896

POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA MATCHED SIBLING TRANSPLANT IN ACUTE LEUKAEMIA

EHA Library, Alaa Elshamy, 293897

RITUXIMAB FOR THE PREVENTION OF ANEMIA POST ABO MAJOR INCOMPATIBLE ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Maria Chiara Finazzi, 293898

COMPARISON OF IMMUNOSUPPRESSIVE AGENT REDUCTION AND DONOR LYMPHOCYTE INFUSION IN CORRECTION OF A MIXED CHIMERISM POST-TRANSPLANTATION IN PATIENT WITH THALASSEMIA

EHA Library, Jianyun Liao, 293899

CO-TRANSPLANTATION OF MESENCHYMAL STEM CELLS IMPROVES THE PROGNOSIS OF ALLO-HSCT IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES: A SINGLE-CENTER RETROSPECTIVE STUDY OF 175 PATIENTS

EHA Library, Ting Yang, 293900

EFFICACY OF DONOR AND ‘THIRD PARTY' DERIVED EBV-SPECIFIC CYTOTOXIC T CELLS FOR TREATMENT OF RITUXIMAB-REFRACTORY EBV-PTLD AFTER ALLO-HSCT IN PEDIATRIC PATIENTS

EHA Library, Xiaodong Wang, 293901

ANALYSIS OF IMPROVED RESULTS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PROMOTED BY KIR MISMATCHING, DONOR KIR3DS1-POSITIVE OR KIR2DS3-NEGATIVE THROUGH A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Ting Yang, 293902

AUTOLOGOUS STEM CELL TRANSPLANTATION IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE ANALYSIS FROM THE LYMPHOMA WORKING PARTY OF THE EBMT

EHA Library, Toby Eyre, 293903

LOWER NRM AND BETTER GRFS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) COMPARED WITH ANTITHYMOCITE GLOBULIN (ATG) IN UNRELATED HEMATOPIETIC TRANSPLANTATION (URD). A SINGLE CENTER EXPERIENCE.

EHA Library, Mariano Berro, 293904

THE IMPORTANCE OF THE REGIONAL PUBLIC CORD BLOOD BANK OF CRETE FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ACCESS OF THE CRETAN POPULATION

EHA Library, Emmanouil Stylianakis, 293905

CURCUMIN ALLEVIATES ORAL MUCOSITIS AND OTHER TOXICITIES ASSOCIATED WITH HIGH-DOSE MELPHALAN BY MODULATING PRO AND ANTI-INFLAMMATORY CYTOKINES

EHA Library, Kritika Katti, 293906

CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE INFECTIONS ARE ASSOCIATED WITH HIGH RATES OF ACUTE GRAFT-VERSUS-HOST DISEASE AND TREATMENT-RELATED MORTALITY

EHA Library, Eleni Gavriilaki, 293907

CRYOTHERAPY VS SUPERSATURATED CALCIUM PHOSPHATE RINSES IN MULTIPLE MYELOMA PATIENTS TREATED WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANT: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL

EHA Library, Dorra Belloumi, 293908

NON-MYELOABLATIVE MATCHED STEM CELL TRANSPLANTATION WITH OPTIONAL REINFORCED STEM CELL INFUSION FOR HEMOGLOBINOPATHIES

EHA Library, Seung-Hwan Shin, 293909

PRETRANSPLANT HIGH FERRITINEMIA IS ASSOCIATED WITH HIGHER RISK OF EARLY DOCUMENTED INFECTIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Nour Ben Adejlil, 293910

ISAVUCONAZOLE IN ALLOGENEIC STEM CELL TRANSPLANTATION. A REAL-LIFE REPORT FROM THE SPANISH GROUP OF TRANSPLANT AND CELLULAR THERAPY (GETH).

EHA Library, Gillen Oarbeascoa, 293911

BEEAM CONDITIONING REGIMEN IS AN EFFICACIOUS AND ECONOMICAL ALTERNATIVE TO BEAM CHEMOTHERAPY

EHA Library, Logan Hahn, 293912

ANTIEMETIC PROPHYLAXIS WITH FOSAPREPITANT IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING AUTOLOGOUS HSCT

EHA Library, Michaela Döring, 293913

UTILITY OF CD4+/CD8+ RATIO IN BRONCHOALVEOLAR LAVAGE FLUID IN DETECTING THE CAUSE OF ACUTE LUNG INJURY IN THE PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hajime Senjo, 293914

THE PROGNOSTIC VALUE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR–LIGAND MISMATCH IN DONOR VERSUS RECIPIENT DIRECTION ON THE OUTCOMES OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Zoya Konova, 293915

CIPROFLOXACIN PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANT: IMPACT ON MORTALITY AND MICROBIOLOGICAL RESISTANCE

EHA Library, Inés Paganini, 293916

FEASIBILITY AND SAFETY OF NON-CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS AUTOLOGOUS TRANSPLANTATION IN MULTIPLE MYELOMA: BICENTRIC STUDY.

EHA Library, Selim Jennane, 293917

FEASIBILITY OF THE EBMT RISK SCORE FOR ASSESSING TRANSPLANT RELATED MORTALITY FOR PATIENTS WITH ACUTE LEUKEMIA TRANSPLANTED AT NATIONAL RESEARCH CENTER FOR HEMATOLOGY, RUSSIA (2009-2019)

EHA Library, Feruza Omarova, 293918

BLOODSTREAM INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A FOUR YEARS SURVEY

EHA Library, Khouloud TOUIHRI, 293919

ASSOCIATION BETWEEN THE KINETICS OF CYTOMEGALOVIRUS REACTIVATION IN TERMS OF THE AREA UNDER THE CURVE OF CYTOMEGALOVIRUS ANTIGENEMIA AND NRM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Junko Takeshita, 293920

OUTCOME OF FLUDARABINE-BUSULFAN-ANTI THYMOCYTE GLOBULIN (FLU-BU-ATG) CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPIETIC STEM CELL TRANSPLANTATION

EHA Library, Ahmed Askar, 293921

PRESENTATION AND MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN REAL-WORLD CLINICAL PRACTICE: A MEDICAL CHART AUDIT

EHA Library, Amandeep Salhotra, 293922

10-YEAR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (RESULTS OF AN ONE-CENTER STUDY)

EHA Library, Maxim Solovev, 293923

CLINICAL OUTCOMES OF POST LYMPHOPROLIFERATIVE DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – SIX-YEAR PERIOD CENTER EXPERIENCE

EHA Library, Carolina Pavao, 293924

5' ECTONUCLEOTIDASE (CD73) MAY PREDICT THE OCCURRENCE OF CGVHD AND GRADE OF AGVHD IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Walaa Elsalakawy, 293925

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH UNFAVORABLE CD34+ CELLS YIELD IN PATIENTS WITH NON- HODGKIN LYMPHOMA

EHA Library, Weiping Liu, 293926

GEMCITABINE AND DOCETAXEL PROTOCOL AS INTENT TO AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH REFRACTORY AND RELAPSED NON HODGKIN LYMPHOMA: SINGLE INSTITUTIONAL PROSPECTIVE PHASE II STUDY

EHA Library, Doaa Hassan, 293927

AN INSPIRING RESULT OF UMBILICAL CORD BLOOD TRANSPLANTATION AFTER ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY IN CHILDREN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fang Liu, 293928

TISSUE-SCALE SPATIAL ANALYSIS OF HEMATOPOIETIC STEM CELL NICHES IN THE FETAL LIVER MICROENVIRONMENT

EHA Library, Cesar Nombela Arrieta, 293929

BONE MARROW MICROENVIRONMENT IN ΒETA-THALASSEMIA: UNRAVELING THE IMPACT OF DEFECTIVE MEGAKARYOCYTES ON HEMATOPOIETIC STEM CELL FUNCTION

EHA Library, Annamaria Aprile, 293930

MITOCHONDRIAL ELECTRON TRANSPORT CHAIN COMPLEX II DYSFUNCTION DRIVES PREMATURE AGING OF HEMATOPOIETIC STEM CELLS

EHA Library, Kaito Harada, 293931

ASSESSMENT OF MUTATION BURDEN IN HEMATOPOIETIC STEM CELL CLONES AS A RESULT OF AGING AND INFLAMMATORY STRESS

EHA Library, Megan Druce, 293932

SINGLE-CELL RNASEQ OF HEMATOPOIETIC PROGENITORS REVEALS ALTERED GENE REGULATORY NETWORKS IN HUMAN AGING

EHA Library, Marina Ainciburu, 293933

HIGH ENERGY DEMAND UPREGULATES GLYCOLYTIC ATP PRODUCTION IN HEMATOPOIETIC STEM CELLS VIA AMPK / PFKFB3 AXIS

EHA Library, Shintaro Watanuki, 293934

THE B-CATENIN-TCF/LEF TRANSCRIPTION COMPLEX SUPPRESSES HEMATOPOIETIC STEM CELL SELF-RENEWAL AND IS DISPENSABLE FOR LEUKEMIA DEVELOPMENT

EHA Library, Petr Daněk, 293935

MITOCHONDRIAL REPROGRAMMING OF HUMAN ERYTHROID PROGENITORS CONTROLS TERMINAL DIFFERENTIATION

EHA Library, Pedro Gonzalez-Menendez, 293937

HEMATOPOIETIC STEM CELLS SUSTAIN MATURE BLOOD CELL PRODUCTION DURING STRESS HEMATOPOIESIS ON THE EXPENSE OF SELF-RENEWAL

EHA Library, Ana-Matea Mikecin Drazic, 293940

EXPRESSION OF ERYTHROPOIETIN RECEPTOR (EPO-R) IS REQUIRED FOR PROPER OSTEOBLAST FUNCTION

EHA Library, Martina Rauner, 293941

TAILORING FOR DEVELOPMENT: A TRANSIENT WAVE OF HSC-DERIVED INNATE LYMPHOID PROGENITORS COLONIZES AND SHAPES THE MOUSE EMBRYO THYMIC ARCHITECTURE.

EHA Library, Ramy ELSAID, 293942

CK2 HAS A KEY ROLE IN HEMATOPOIESIS FROM HSC TO MORE DIFFERENTIATED CELLS.

EHA Library, Laura Quotti Tubi, 293943

NOVEL ROLE(S) FOR IRF5 IN CONTROLLING MYELOPOIESIS AND ERYTHROPOIESIS

EHA Library, Lionel Blanc, 293945

OPTIMISATION OF LEUKEMIC AND HEMATOPOIETIC 3D MODELS FOR COMPARATIVE BIO-PHYSICAL ANALYSIS AND THERAPEUTIC SCREENING

EHA Library, Jenna James, 293946

IRS2 IS REQUIRED TO EFFICIENT ERYTHROID AND MEGAKARYOCYTIC DIFFERENTIATION IN MURINE MODEL

EHA Library, Bruna Alves Fenerich, 293947

DEVELOPMENT OF CULTURE SYSTEM FOR HUMAN HEMATOPOIETIC STEM CELLS WITHOUT CYTOKINES

EHA Library, Masatoshi Sakurai, 293948

ANTIOXIDANTS PROTECT HEMATOPOIETIC STEM/PROGENITOR CELLS AGAINST OXIDATIVE STRESS AND LOSS OF STEMNESS PROPERTIES DURING EX VIVO MANIPULATION IN CELL AND GENE THERAPY PROTOCOLS

EHA Library, Elia Henry, 293949

STEM CELL BASED HETEROGENEITY OF INTERFERON SIGNALING DURING HEMATOPOIETIC DEVELOPMENT

EHA Library, Paula Werner, 293950

CHRONIC PSYCHOLOGICAL STRESS DIFFERENTIALLY ALTERS BONE MARROW AND SPLEEN MICROENVIRONMENT TOWARD ENHANCED ERYTHROPOIESIS

EHA Library, Sanja Momčilović, 293951

KINETICS AND COMPOSITION OF HEMATOPOIETIC STEM/PROGENITORS MOBILIZED CELLS UPON G-CSF AND PLERIXAFOR ADMINISTRATION IN TRANSPLANT DONOR OR PATIENTS UNDERGOING AUTOLOGOUS GENE THERAPY.

EHA Library, Luca Basso-Ricci, 293952

CLONAL HAEMOPOIESIS OF INDETERMINATE POTENTIAL AND MYELOPROLIFERATIVE DISEASE ARE ASSOCIATED WITH INCREASED EPIGENETIC AGE

EHA Library, Kristina Kirschner, 293953

UNSUPERVISED FLOWSOM ANALYSIS OF CLASSICAL FLOW CYTOMETRY PANELS SELF-GENERATES DISCRETE CELL SUBSETS OF NORMAL BONE MARROW.

EHA Library, Marie Christine Béné, 293954

THE BET INHIBITOR CPI203 PROMOTES EX VIVO EXPANSION OF CORD BLOOD LONG-TERM REPOPULATING HSCS AND MEGAKARYOCYTES

EHA Library, George Adigbli, 293955

IMPORTANT ROLE OF SKIN MESENCHYMAL STEM CELL SUBSETS IN NORMAL AND LEUKEMIC STEM CELL PROLIFERATION

EHA Library, Lakshmi Sandhow, 293956

CONDITIONAL EXPRESSION OF HOXA9 IN A HUMAN PLURIPOTENT STEM CELL DERIVED MODEL OF HEMATOPOIESIS.

EHA Library, Emma Collins, 293957

GENERATION OF HUMANIZED BONE MARROW-LIKE NICHE FOR LEUKEMIC XENOTRANSPLANTATION IN MICE: COMPARISON OF BIOMATERIALS

EHA Library, Martin Culen, 293958

THE IMBALANCED CYTOKINE PROFILE IN PATIENTS WITH PRE-LEUKEMIA

EHA Library, Amalie Bach Nielsen, 293959

PARKINSON'S DISEASE IS NOT ASSOCIATED WITH CLONAL HAEMATOPOIESIS

EHA Library, William DUNN, 293960

INHIBITION OF THE ANTI-APOPTOTIC PROTEIN MCL-1 SEVERELY SUPPRESSES HUMAN HEMATOPOIESIS

EHA Library, Miriam Erlacher, 293961

TUMOR-ASSOCIATED SIGNS OF A BONE MARROW HEMATOPOIETIC NICHE IN PATIENTS WITH MULTIPLE MYELOMA AFTER THERAPY

EHA Library, Natalya Semenova, 293962

A PHASE 1 STUDY OF CT103A, A FULLY HUMAN BCMA TARGETING CAR T CELL, IN SUBJECTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, chunrui li, 293963

ALLELE-SPECIFIC CRISPR/CAS9 GENE-EDITING STRATEGIES FOR ELANE MUTATIONS IN PRIMARY HSPCS OF SEVERE CONGENITAL NEUTROPENIA PATIENTS

EHA Library, Masoud Nasri, 293964

EFFICIENT CORRECTION OF HAX1 MUTATIONS IN PRIMARY HSPCS OF SEVERE CONGENITAL NEUTROPENIA PATIENTS USING CRISPR/CAS9 GENE-EDITING

EHA Library, Malte Ritter, 293965

A FLEXIBLE ISOGENEIC HUMANIZED MOUSE MODEL TO ASSESS CAR T CELL HEMATOLOGIC TOXICITY REVEALS MARROW-INDUCED CAR T CELL DYSFUNCTION.

EHA Library, Jacob Appelbaum, 293966

NPM1-MUTATED AML IS SUSCEPTIBLE TO SPECIFIC T CELLS DERIVED FROM NPM1 AND OTHER IMMUNOGENIC ANTIGENS AND IMMUNE RESPONSES INCREASE BY IMMUNE CHECKPOINT MANIPULATION

EHA Library, Jochen Greiner, 293967

T CELL ENGAGING BISPECIFIC ANTIBODIES GENERATED FROM A NOVEL, LARGE AND DIVERSE CD3 PANEL DEMONSTRATE FUNCTIONALITY UNCOUPLED FROM AFFINITY

EHA Library, Pieter Fokko Van Loo, 293968

CORD BLOOD DERIVED NK CELLS AS AN ATTRACTIVE OPTION TO ENHANCE THE EFFICACY OF CART CELL THERAPY

EHA Library, Mireia Bachiller, 293969

CLONAL TRACKING OF HEMATOPOIETIC RECONSTITUTION DYNAMICS AFTER BONE MARROW OR MOBILIZED PERIPHERAL BLOOD STEM CELL GENE THERAPY

EHA Library, Serena Scala, 293970

COMPARATIVE ANALYSES OF NKP30 CAR REDIRECTED HUMAN TCR-POSITIVE AND TCR-KNOCKDOWN T LYMPHOCYTES FOR CELLULAR IMMUNOTHERAPY

EHA Library, Sedigheh Givi, 293972

DEEP CHARACTERIZATION OF MBIL21 EX VIVO-EXPANDED NK CELLS USING MASS CYTOMETRY, FUNCTIONAL ASSAYS, AND RNA SEQUENCING ESTABLISHES PRODUCT CONSISTENCY ACROSS DIFFERENT MANUFACTURING SITES AND SYSTEMS

EHA Library, Dean A Lee, 293973

HIGHLY EFFICIENT THERAPEUTIC GENOME EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS TO CURE SICKLE CELL DISEASE AND THALASSEMIA

EHA Library, Han Verhagen, 293974

DEVELOPMENT OF A HUMANISED IMMUNOCOMPETENT MOUSE MODEL TO STUDY THE RELAPSE VACCINE DCP-001

EHA Library, Satwinder Kaur Singh, 293975

CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED NATURAL KILLER (NK) CELLS: PRECISION TOOLS FOR CANCER IMMUNOTHERAPY

EHA Library, Michael Morgan, 293976

DUAL FUNCTIONING, HUMAN CHROMATIN INSULATORS INCORPORATED IN LENTI-VIRAL VECTORS; A PLATFORM FOR OVERCOMING CURRENT LIMITATIONS OF HEMATOPOIETIC STEM CELL (HSC) GENE THERAPY

EHA Library, Penelope Georgia Papayanni, 293977

MULTI-TECHNIQUE FOLLOW-UP OF LYMPHOMA PATIENTS UNDERGOING COMMERCIAL CAR-T CELL THERAPY: EXPERIENCE FROM A SINGLE CENTRE

EHA Library, Rebeca Bailén, 293978

BETIBEGLOGENE AUTOTEMCEL (LENTIGLOBIN) IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA AND Β0/Β0, B+IVS-I-110/B+IVS-I-110, OR Β0/B+IVS-I-110 GENOTYPES: UPDATED RESULTS FROM THE HGB-212 STUDY

EHA Library, Evangelia Yannaki, 293980

CAR T-CELL THERAPY CAN IMPROVE THE OUTCOME OF RELAPSED/REFRACTORY DOUBLE-HIT LYMPHOMA

EHA Library, Jia Wei, 293981

GENE THERAPY WITH THE LENTIVIRAL VECTOR TNS9.3.55 PRODUCES LONG-TERM IMPROVEMENT IN SEVERE ß-THALASSEMIA

EHA Library, Simona Raso, 293982

ELIMINATION OF MULTI-DRUG RESISTANT HEMATOLOGICAL MALIGNANT CELLS RESULTING IN CURE USING NON-ENGRAFTING INTENTIONALLY MISMATCHED IL-2 ACTIVATED DONOR LYMPHOCYTES

EHA Library, Shimon Slavin, 293983

RECENT PROGRESS IN THE DEVELOPMENT OF AMT-061 (ETRANACOGENE DEZAPARVOVEC) FOR PERSONS WITH SEVERE OR MODERATELY SEVERE HEMOPHILIA B

EHA Library, Wolfgang Miesbach, 293984

OUTCOMES OF ANTI-CD19 CAR-T CELL THERAPY FOR TRANSFORMED NON FOLLICULAR LYMPHOMA

EHA Library, Lucía Rubio Lopes-Garcia, 293985

A METANALYSES OF THE WORLDWIDE EXPERIENCE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL GENE THERAPY FOR MONOGENIC DISORDERS

EHA Library, Francesca Tucci, 293986

GENE THERAPY FOR FANCONI ANEMIA: A REPORT ON OUTCOMES IN NINE PATIENTS

EHA Library, Shameel Shafqat, 293987

FEASIBILITY OF ALLOGENEIC NATURAL KILLER CELLS, MG4101 IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMAS; A PHASE 1, OPEN-LABEL, MULTICENTER STUDY

EHA Library, Dok Hyun Yoon, 293988

TMTV CORRELATES WITH EARLY PROGRESSION (EP) AFTER CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Sophie Bernard, 293989

GRANULOCYTE COLONY STIMULATING FACTOR (GCSF) ADMINISTRATION DOES NOT AFFECT PREVALENCE AND SEVERITY OF CRS, ICANS NOR OUTCOME IN PATIENTS WITH R/R LARGE B CELLS LYMPHOMAS TREATED BY CD19 CAR-T

EHA Library, Eugenio Galli, 293990

ENTECAVIR PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN PATIENTS WITH CAR T-CELL THERAPY

EHA Library, Liang Huang, 293991

REFRACTORY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS/MACROPHAGE-ACTIVATION SYNDROME (HLH/MAS) FOLLOWING TREATMENT WITH TISAGENLECLEUCEL FOR REFRACTORY B-CELL LYMPHOMA.

EHA Library, Ignacio Gómez-Centurión, 293992

IMMUNOLOGY-ONCOLOGY (I-O) DRUGS IN THE TREATMENT STRATEGIES FOR RELAPSE AFTER ANTI-CD19 CAR T CELLS IN PATIENTS WITH REFRACTORY/RELAPSED LARGE B CELL LYMPHOMA

EHA Library, Roberta Di Blasi, 293993

CD19-SPECIFIC CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY NON B-CELL ACUTE LEUKEMIA WITH CD19 EXPRESSION

EHA Library, Shuangyou Liu, 293994

HIGH-GRADE NEUROLOGICAL TOXICITY FOLLOWING CD19 CAR-T THERAPY: OUTCOMES FROM A SINGLE CENTRE EXPERIENCE

EHA Library, Strachan Mackenzie, 293995

CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - THE MUNICH REAL LIFE EXPERIENCE

EHA Library, Veit Bücklein, 293996

DICLOFENAC IN THE MANAGEMENT OF CYTOKINE RELEASE SYNDROME AFTER CAR-T INFUSION IN B-ALL PEDIATRIC PATIENTS

EHA Library, Sara Napolitano, 293997

START OF THE PROCESSING OF LYMPHAPHERESIS IN A HOSPITAL AND IMPACT ON THE GENERATION OF CAR-T IN THE PRODUCTION CENTER

EHA Library, María Liz Paciello Coronel, 293998

REFRACTORY SEVERE ICANS IN A PATIENT TREATED WITH AXICABTAGENE CILOLEUCEL SUBSEQUENTLY FOUND TO HAVE SUSPECTED CNS DISEASE.

EHA Library, Nikesh Chavda, 293999